98%
921
2 minutes
20
Beak and feather disease virus (BFDV) belongs to the Circoviridae family, which has a relatively simple replication mechanism. As BFDV lacks a mature cell culture system, a novel mini-replicon system based on the reporter plasmid that contains the origin of replication, which can bind to the Rep protein expressed from another plasmid and thus trigger its replication and induce/increase luminescence was developed. The dual-luciferase assay was used in this system to measure replicative efficiency by comparing relative light units (RLU) of firefly luciferase. Linear relationships between the luciferase activity of the reporter plasmids with the BFDV origin of replication and the amounts of the Rep protein and vice versa were found, suggesting the mini-replicon system can be used to quantify viral replication. Moreover, the activities of reporter plasmids driven by mutated Rep proteins or the activities of reporter plasmids with mutations were significantly downregulated. The Rep and Cap promoter activities can be characterized using this luciferase reporter system. Notably, the RLU of the reporter plasmid was considerably inhibited in the presence of sodium orthovanadate (NaVO). When BFDV-infected birds were treated with NaVO, the viral loads of BFDV rapidly decreased. In conclusion, this mini-replicon reporter gene-based system provides a practical means to screen for anti-viral drug candidates.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gene.2023.147371 | DOI Listing |
J Control Release
September 2025
State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai 200237, PR China. Electronic address:
Live bacterial therapeutics (LBT) represent a transformative modality for managing refractory chronic diseases. However, the absence of optimized microbial chassis systems is a significant barrier to clinical translation. To bridge this gap, we engineered Escherichia coli Nissle 1917 (EcN) into a versatile platform that meets the requirements for strain development and clinical application.
View Article and Find Full Text PDFPrev Nutr Food Sci
August 2025
College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 61186, Korea.
This study developed an effective combination of and (SNE) and evaluated its anti-inflammatory and anti-hyperuricemic effects under conditions. First, the effect of SNE was tested on xanthine oxidase (XOD) activity. To investigate the anti-inflammatory effect of SNE, nitric oxide (NO) production was detected by Griess assay, and proinflammatory cytokines were measured by enzyme-linked immunosorbent assay in RAW264.
View Article and Find Full Text PDFFront Microbiol
August 2025
School of Bioengineering, Qilu University of Technology, Shandong Academy of Science, Jinan, China.
The nisin-controlled gene expression (NICE) system is an efficient and promising gene expression system for . To enhance the expression efficiency of the NICE system in ATCC19258, an inducible expression vector, pNZ8148-PnisA-gfp-PnisR-nisR-nisK, containing the regulatory element NisR/K and the promoter PnisR, was first constructed using the basic plasmid pNZ8148. Green fluorescent protein (GFP), as the reporter protein, was cloned downstream of PnisA in the vector pNZ8148 to detect protein expression.
View Article and Find Full Text PDFPLoS One
September 2025
Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Mammalian cells exhibit three autophagy mechanisms: macroautophagy, microautophagy (MIA), and chaperone-mediated autophagy (CMA), each employing unique mechanisms for transporting cellular material to the lysosome for degradation. MIA involves the engulfment of proteins via lysosomes/late endosomes through membrane invagination, while CMA directly imports cytosolic proteins into lysosomes, selectively targeting those harboring the KFERQ pentapeptide motif, helped by the chaperone HSC70. Despite the identification of several genetic markers of these pathways, our understanding of the underlying mechanisms, particularly in MIA and CMA, remains limited.
View Article and Find Full Text PDFJ Ethnopharmacol
August 2025
Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Collaborative Innovation Center of Prevention and Treatment of Major Diseases By Chinese and Western Medicine, Henan Province, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine,
Ethnopharmacological Relevance: Huanshaodan (HSD) is a Traditional Chinese Medicine Compound Prescription, traditionally used in the clinical treatment of Alzheimer's disease (AD) in China. Nevertheless, its bioactive constituents and mechanistic basis remain poorly understood.
Aim Of The Study: To identify the components derived from HSD that inhibit SIRT2 and investigate the underlying mechanisms in mitigating AD pathogenesis.